Ingo Bauerfeind Selected Research

Ingo Bauerfeind Research Topics

Disease

41	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2003
17	Neoplasms (Cancer) 12/2020 - 01/2003
5	Neoplasm Metastasis (Metastasis) 10/2021 - 10/2008
2	Triple Negative Breast Neoplasms 01/2021 - 12/2020
2	Cognitive Dysfunction 10/2017 - 12/2010
2	Pathologic Complete Response 04/2010 - 06/2009
2	Ovarian Neoplasms (Ovarian Cancer) 04/2009 - 09/2006
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2019
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2017
1	Chemotherapy-Related Cognitive Impairment 12/2010
1	Febrile Neutropenia 04/2010
1	Conjunctivitis 04/2010
1	Cardiotoxicity 04/2010
1	Diarrhea 04/2010
1	Hand-Foot Syndrome 04/2010
1	Edema (Dropsy) 04/2010
1	Neutropenia 06/2009
1	Infections 06/2009
1	Anemia 06/2009
1	Thrombocytopenia (Thrombopenia) 06/2009
1	Malnutrition (Nutritional Deficiencies) 04/2009
1	Weight Loss (Weight Reduction) 04/2009
1	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2003

Drug/Important Bio-Agent (IBA)

5	Hormones (Hormone)IBA 12/2020 - 01/2003
4	Epirubicin (Ellence)FDA LinkGeneric 04/2010 - 05/2007
3	taxaneIBA 01/2021 - 04/2010
3	AnthracyclinesIBA 01/2021 - 04/2010
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2010 - 05/2007
2	human ERBB2 proteinIBA 12/2020 - 04/2010
2	Carcinoembryonic AntigenIBA 08/2011 - 03/2008
2	Trastuzumab (Herceptin)FDA Link 04/2010 - 04/2010
2	Capecitabine (Xeloda)FDA Link 04/2010 - 04/2010
2	Docetaxel (Taxotere)FDA Link 04/2010 - 04/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2009 - 05/2007
2	Cytostatic AgentsIBA 01/2008 - 03/2006
2	SteroidsIBA 05/2003 - 01/2003
1	Pharmaceutical PreparationsIBA 09/2016
1	Taxoids (Taxanes)IBA 01/2016
1	Fluorouracil (Carac)FDA LinkGeneric 01/2016
1	OF 743IBA 08/2015
1	Ibandronic Acid (Boniva)FDA Link 10/2013
1	Diphosphonates (Bisphosphonates)IBA 10/2013
1	Mucin-1 (CA 15-3 Antigen)IBA 08/2011
1	ErbB Receptors (EGF Receptor)IBA 04/2010
1	Growth Factor ReceptorsIBA 01/2010
1	Letrozole (Femara)FDA LinkGeneric 01/2010
1	Estrogen ReceptorsIBA 01/2010
1	Lapatinib (GW572016)FDA Link 01/2010
1	Aromatase InhibitorsIBA 08/2009
1	Estrogens (Estrogen)FDA Link 11/2008
1	Annexin A5IBA 10/2008
1	Thrombin FDA Link 10/2008
1	Prothrombin (Factor II)IBA 10/2008
1	AntigensIBA 03/2008
1	Biomarkers (Surrogate Marker)IBA 03/2008
1	von Willebrand FactorIBA 03/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2004
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2003
1	Cyclin D1IBA 05/2003
1	ParaffinIBA 05/2003
1	EnzymesIBA 01/2003
1	ImmunosorbentsIBA 01/2003
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2003

Therapy/Procedure

21	Therapeutics 12/2020 - 01/2003
14	Drug Therapy (Chemotherapy) 04/2019 - 03/2004
12	Neoadjuvant Therapy 10/2021 - 05/2007
1	Operative Surgical Procedures 10/2021
1	Radiotherapy 10/2021
1	Mastectomy (Mammectomy) 01/2017
1	Life Support Care 06/2013
1	Prophylactic Mastectomy 09/2006
1	Lymph Node Excision (Lymph Node Dissection) 04/2004
1	Radical Mastectomy 03/2004